Amgen Inc. sell Bank of America Co.
Start price
05.03.25
/
50%
€293.05
Target price
05.03.26
€272.83
Performance (%)
2.88%
Price
26.01.26
€294.35
Summary
This prediction is currently active. With a performance of 2.88%, the SELL prediction by Bank_of_America_Co_ for Amgen Inc. is trending in the wrong direction Dividends of €7.14 are taken into consideration when calculating the performance. This prediction currently runs until 05.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.565% | 4.565% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Co. from $275.00 to $294.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat